The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2024 / Oct / SERS Chip Diagnoses Heart Attacks in Five Minutes
Clinical Spectroscopy

SERS Chip Diagnoses Heart Attacks in Five Minutes

New metasurface-based blood test detects cardiac biomarkers in just minutes, offering faster diagnosis in clinical settings

10/29/2024 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Poll

Share

Objective:

To develop a rapid blood test for diagnosing heart attacks using a plasmonic metasurface and surface-enhanced Raman spectroscopy (SERS).

Approach:
  • Technology Development: A metasurface-enhanced chip was created to amplify signals for detecting cardiac biomarkers in blood samples.
  • Biomarker Detection: The system detects key biomarkers like CK-MB, Mb, and cTnI in 5–7 minutes, significantly faster than traditional methods.
  • Signal Measurement: The technology tracks frequency shifts in the SERS signal to accurately measure multiple biomarkers simultaneously.
Key Findings:
  • The new test can diagnose heart attacks in 5–7 minutes.
  • It detects biomarkers at ultra-low concentrations with high sensitivity.
  • The approach mitigates signal fluctuations common in traditional SERS methods.
Interpretation:

Limitations:
  • Further refinement of the device is needed.
  • Clinical trials must be expanded to evaluate performance across diverse patient populations.
Conclusion:

Sources:
  • Johns Hopkins University

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

 This Week’s Mass Spec News
Clinical
This Week’s Mass Spec News

April 4, 2025

2 min read

Spit It Out
Clinical
Spit It Out

December 4, 2024

1 min read

Saliva-based PA-MS test detects paracetamol overdose in just 10 minutes

Let Me See That Brain
Clinical
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

Meeting Mpox Where It’s At
Clinical
Meeting Mpox Where It’s At

December 17, 2024

1 min read

New optical biosensor offers mpox virus detection in 20 minutes

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.